Published in Nat Mater on March 20, 2017
Modular tissue engineering for the vascularization of subcutaneously transplanted pancreatic islets. Proc Natl Acad Sci U S A (2017) 0.75
Designing biomaterials with immunomodulatory properties for tissue engineering and regenerative medicine. Bioeng Transl Med (2017) 0.75
Regenerative medicine and cell-based approaches to restore pancreatic function. Nat Rev Gastroenterol Hepatol (2017) 0.75
Alternative activation of macrophages. Nat Rev Immunol (2003) 27.53
Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am (2007) 24.18
Antiinflammatory action of glucocorticoids--new mechanisms for old drugs. N Engl J Med (2005) 8.65
Foreign body reaction to biomaterials. Semin Immunol (2007) 8.32
NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood (2002) 7.78
Monocyte recruitment during infection and inflammation. Nat Rev Immunol (2011) 7.55
Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med (2012) 6.15
CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat Med (2013) 5.04
First-in-human testing of a wirelessly controlled drug delivery microchip. Sci Transl Med (2012) 3.56
The IL-21 receptor augments Th2 effector function and alternative macrophage activation. J Clin Invest (2006) 3.33
Alginate: properties and biomedical applications. Prog Polym Sci (2012) 3.18
Macrophages and tissue injury: agents of defense or destruction? Annu Rev Pharmacol Toxicol (2011) 2.28
Combinatorial hydrogel library enables identification of materials that mitigate the foreign body response in primates. Nat Biotechnol (2016) 2.04
Adverse effects of bisphosphonates: current issues. J Support Oncol (2008) 1.90
Size- and shape-dependent foreign body immune response to materials implanted in rodents and non-human primates. Nat Mater (2015) 1.90
The CC chemokine ligand, CCL2/MCP1, participates in macrophage fusion and foreign body giant cell formation. Am J Pathol (2004) 1.88
Regulatory immune cells in transplantation. Nat Rev Immunol (2012) 1.82
Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580. Proc Natl Acad Sci U S A (2005) 1.75
Monocyte-like and mature macrophages produce CXCL13 (B cell-attracting chemokine 1) in inflammatory lesions with lymphoid neogenesis. Blood (2004) 1.61
Alginate-based microcapsules for immunoisolation of pancreatic islets. Biomaterials (2006) 1.58
Safety and viability of microencapsulated human islets transplanted into diabetic humans. Diabetes Care (2009) 1.48
B cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas. Cancer Cell (2014) 1.43
A review of the foreign-body response to subcutaneously-implanted devices: the role of macrophages and cytokines in biofouling and fibrosis. J Diabetes Sci Technol (2008) 1.40
The road to biological pacing. Nat Rev Cardiol (2011) 1.27
Macroscale delivery systems for molecular and cellular payloads. Nat Mater (2013) 1.25
Mediators of the inflammatory response to joint replacement devices. Nat Rev Rheumatol (2011) 1.23
Sustained function of alginate-encapsulated human islet cell implants in the peritoneal cavity of mice leading to a pilot study in a type 1 diabetic patient. Diabetologia (2013) 1.22
Differential anti-inflammatory effects of immunosuppressive drugs: cyclosporin, rapamycin and FK-506 on inducible nitric oxide synthase, nitric oxide, cyclooxygenase-2 and PGE2 production. Inflamm Res (2000) 1.21
Porous implants modulate healing and induce shifts in local macrophage polarization in the foreign body reaction. Ann Biomed Eng (2013) 1.14
Rapid biocompatibility analysis of materials via in vivo fluorescence imaging of mouse models. PLoS One (2010) 1.10
Biocompatible materials for continuous glucose monitoring devices. Chem Rev (2013) 1.10
Quantitative in vivo cytokine analysis at synthetic biomaterial implant sites. J Biomed Mater Res A (2009) 1.10
Perspectives and challenges in tissue engineering and regenerative medicine. Adv Mater (2009) 1.09
The effect of host factors and capsule composition on the cellular overgrowth on implanted alginate capsules. J Biomed Mater Res (2001) 1.09
A review of organic and inorganic biomaterials for neural interfaces. Adv Mater (2014) 1.05
C-X-C motif chemokine 13 (CXCL13) is a prognostic biomarker of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2014) 1.03
Translating materials design to the clinic. Nat Mater (2013) 1.03
Cytokine receptor profile of arthroplasty macrophages, foreign body giant cells and mature osteoclasts. Acta Orthop Scand (1999) 0.95
Enhanced function of immuno-isolated islets in diabetes therapy by co-encapsulation with an anti-inflammatory drug. Biomaterials (2013) 0.94
All charged up about implanted biomaterials. Nat Biotechnol (2013) 0.94
Combating medical device fouling. Trends Biotechnol (2014) 0.93
Inflammatory response to peritoneal implantation of alginate-poly-L-lysine microcapsules. Biomaterials (2005) 0.93
TIMP-1 is a key factor of fibrogenic response to bleomycin in mouse lung. Int J Immunopathol Pharmacol (2006) 0.90
Islet encapsulation: advances and obstacles. Diabetologia (2013) 0.88
The role of pathogen-associated molecular patterns in inflammatory responses against alginate based microcapsules. J Control Release (2013) 0.87
The posterior chamber phakic refractive lens (PRL): a review. Eye (Lond) (2012) 0.85
Neutrophil Responses to Sterile Implant Materials. PLoS One (2015) 0.79
CX3CR1 deficiency promotes muscle repair and regeneration by enhancing macrophage ApoE production. Nat Commun (2015) 0.79
Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice. Nat Med (2016) 2.15
Combinatorial hydrogel library enables identification of materials that mitigate the foreign body response in primates. Nat Biotechnol (2016) 2.04
Size- and shape-dependent foreign body immune response to materials implanted in rodents and non-human primates. Nat Mater (2015) 1.90
In vivo correction of anaemia in β-thalassemic mice by γPNA-mediated gene editing with nanoparticle delivery. Nat Commun (2016) 0.86
Immune-modulatory alginate protects mesenchymal stem cells for sustained delivery of reparative factors to ischemic myocardium. Biomater Sci (2020) 0.75